Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases

27 Jun 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Mosquito-borne diseases and control
Share to Retinal Development and Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32603815
DOI: 10.1016/j.addr.2020.06.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseasesPMID 32603815Read ↗

Therapeutic applications of CRISPR /Cas9 gene editing technology for the treatment of ocular diseasesSemantic proximity Read ↗

The application and progression of CRISPR/Cas9 technology in ophthalmological diseasesSemantic proximity Read ↗

Precision genome editing in the eye.Semantic proximity Read ↗

The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Semantic proximity Read ↗

Gene Therapy in the Anterior Eye SegmentSemantic proximity Read ↗

Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnologySemantic proximity Read ↗

From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseasesSemantic proximity Read ↗

Genome editing, a superior therapy for inherited retinal diseasesSemantic proximity Read ↗

CRISPR Interference-Potential Application in Retinal Disease.Semantic proximity Read ↗

Genome-Editing Strategies for Treating Human Retinal DegenerationsSemantic proximity Read ↗

Revolution in Gene Medicine Therapy and Genome TherapySemantic proximity Read ↗

Gene therapy for ocular disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.